Medical researchers report on a new mechanism that controls blood cell function and several possible molecular targets for treating myelodysplasia syndromes (MDS) – a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells. MDS can lead to acute myeloid leukemia (AML), a fast-spreading blood cancer that can be deadly if not treated promptly. The authors report that overexpression of a protein called TRAF6 in hematopoietic (blood) cells drives the onset of MDS.
from Top Health News – ScienceDaily http://ift.tt/2iuENN5
from Tumblr http://ift.tt/2iJb2ra
No comments:
Post a Comment